A co-culture model to study modulators of tumor immune evasion through scalable arrayed CRISPR-interference screens

Area of Science:

• Immunology
• Cancer Biology
• Genetics

Background:

• Cancer cells evade immune surveillance through various mechanisms, impacting immunotherapy efficacy.
• The PD-1/PD-L1 pathway is a known target, but alternative evasion strategies remain underexplored.
• Understanding these alternative mechanisms is crucial for improving patient responses to immune checkpoint inhibitors.

Purpose of the Study:

• To develop and validate a novel co-culture model for studying tumor immune evasion.
• To establish a high-throughput screening protocol for identifying genes involved in immune evasion.
• To provide a framework for systematically discovering new mechanisms of cancer immune evasion.

Main Methods:

• A co-culture system pairing reporter T-cells with melanoma cell lines with distinct immune evasion profiles.
• Development of a scalable, high-throughput lentiviral arrayed CRISPR interference (CRISPRi) screening protocol.
• Gene perturbation in both T-cells and melanoma cells to identify modulators of tumor immune evasion.

Main Results:

• Functional validation of the co-culture model system for studying tumor-immune interactions.
• Demonstration of the CRISPRi screening protocol's performance by modulating known immune regulators.
• Successful identification of genes influencing tumor immune evasion characteristics.

Conclusions:

• The developed co-culture model and CRISPRi screening protocol offer a robust platform for investigating tumor immune evasion.
• This framework enables systematic exploration of novel mechanisms beyond PD-1/PD-L1.
• The findings pave the way for identifying new therapeutic targets to enhance immunotherapy response.